Filing Details
- Accession Number:
- 0001179110-13-006723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-11 21:47:55
- Reporting Period:
- 2013-04-11
- Filing Date:
- 2013-04-11
- Accepted Time:
- 2013-04-11 21:47:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235942 | J Antonio Lopez Grillo | C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-04-11 | 3,164 | $28.55 | 9,764 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-04-11 | 5,000 | $35.18 | 14,764 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-04-11 | 5,000 | $30.28 | 19,764 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-04-11 | 13,164 | $98.77 | 6,600 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-04-11 | 10,000 | $12.87 | 16,600 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-04-11 | 10,000 | $39.84 | 26,600 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-04-11 | 10,000 | $31.72 | 36,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-04-11 | 30,000 | $95.83 | 6,600 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-04-11 | 3,164 | $0.00 | 3,164 | $28.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-04-11 | 5,000 | $0.00 | 5,000 | $35.18 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-04-11 | 5,000 | $0.00 | 5,000 | $30.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-04-11 | 10,000 | $0.00 | 10,000 | $12.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-04-11 | 10,000 | $0.00 | 10,000 | $39.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-04-11 | 10,000 | $0.00 | 10,000 | $31.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-31 | No | 4 | M | Direct | |
| 0 | 2021-03-31 | No | 4 | M | Direct | |
| 0 | 2020-03-31 | No | 4 | M | Direct | |
| 0 | 2016-08-14 | No | 4 | M | Direct | |
| 0 | 2018-08-12 | No | 4 | M | Direct | |
| 0 | 2017-08-13 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to 10b5-1 plan.
- The shares were sold at prices ranging from $95.83 to $96.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
